Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Friday, December 7, 2018

Do active video games improve motor function in people with developmental disabilities? A meta-analysis of randomized-controlled trials.

Related Articles

Do active video games improve motor function in people with developmental disabilities? A meta-analysis of randomized-controlled trials.

Arch Phys Med Rehabil. 2018 Nov 30;:

Authors: Hocking DR, Farhat H, Gavrila R, Caeyenberghs K, Shields N

Abstract
OBJECTIVE: To conduct a meta-analysis to examine the effectiveness of active video games (AVGs) interventions on motor function in people with developmental disabilities.
DATA SOURCES: An electronic search of seven databases (Pubmed, EbscoHost, Informit, Scopus, ScienceDirect, Proquest, and PsychInfo) was conducted for randomized controlled trials (RCTs) evaluating active video games to improve motor function in people with developmental disability, published through to May 2018.
STUDY SELECTION: Only articles in a peer-reviewed journal in English were selected, and screened by two independent reviewers for RCTs that compared AVGs to conventional therapy. Twelve RCTs involving 370 people with developmental disabilities met the inclusion criteria for quantitative analysis.
DATA EXTRACTION: Two independent reviewers assessed risk of bias and study quality using the Egger's R, GRADE and TiDier checklists.
DATA SYNTHESIS: Three meta-analyses revealed a large effect size for AVGs to improve gross motor skills (Hedge's g = 0.833, CI = 0.247 to 1.420), small to medium effects for balance (g = 0.458, CI = 0.023, 0.948), and a small, non-significant effect for functional mobility (g = 0.425, CI = -0.03, 0.881). Training frequency (i.e. number of sessions per week) moderated the effect of AVGs on motor function in people with developmental disabilities.
CONCLUSION: We conclude that AVGs show task-specific effectiveness for gross motor skills but the effects are moderated by training intensity. However, due to the low number of trials, diverse diagnoses, variable dosage and multiple outcome measures of the included trials, these results need to be interpreted with caution.

PMID: 30508504 [PubMed - as supplied by publisher]



from PubMed via alexandrossfakianakis on Inoreader https://ift.tt/2RHtPVA

No comments:

Post a Comment